Clinical Trials Details

ECOG- EAY131 MATCH (Any Cancer)

Molecular Analysis for Therapy Choice (MATCH) Histologically documented Solid Tumors or Lymphoma or multiple Myeloma Must have progressed following at least one line of standard therapy AND no other approved/standard therapy available that has been shown to prolong overall survival.

Objective

Must have progressed following at least one line of standard therapy AND no other approved/standard therapy available that has been shown to prolong overall survival.

Clinical Trial Categories

  • Cancers and Other Neoplasms